rs886039269
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001242896.3(DEPDC5):c.3994C>T(p.Arg1332Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001242896.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEPDC5 | NM_001242896.3 | c.3994C>T | p.Arg1332Ter | stop_gained | 38/43 | ENST00000651528.2 | NP_001229825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEPDC5 | ENST00000651528.2 | c.3994C>T | p.Arg1332Ter | stop_gained | 38/43 | NM_001242896.3 | ENSP00000498382 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461800Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727190
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Epilepsy, familial focal, with variable foci 1 Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Oct 02, 2021 | Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant has been reported as pathogenic (ClinVar ID: VCV000264742.2).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Nov 11, 2022 | The DEPDC5 c.3994C>T variant is classified as PATHOGENIC (PVS1, PS4) The DEPDC5 c.3994C>T variant is a single nucleotide change which is predicted to result in premature termination of the protein product at codon 1332 (PVS1). The variant has been reported in multiple individuals with focal epilepsy (PMID:30093711; PS4). This variant is absent from population databases but has been reported in dbSNP (rs886039269) and in the HGMD database: CM160826. It has been reported as pathogenic by other diagnostic laboratories (ClinVar Variation ID: 264742). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2017 | The p.R1332* variant (also known as c.3994C>T), located in coding exon 37 of the DEPDC5 gene, results from a C to T substitution at nucleotide position 3994. This changes the amino acid from an arginine to a stop codon within coding exon 37. In one study, this mutation was detected in an individual with temporal lobe epilepsy and focal cortical dysplasia (Ricos MG et al. Ann. Neurol., 2016 Jan;79:120-31). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
See cases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Mar 02, 2020 | ACMG classification criteria: PVS1, PS4, PM2 - |
Familial focal epilepsy with variable foci Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 06, 2021 | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in DEPDC5 are known to be pathogenic (PMID: 23542697, 23542701). This variant has been observed in individuals with temporal lobe epilepsy and sudden unexpected death in epilepsy as well as one unaffected individual (PMID: 26505888, 26704558). ClinVar contains an entry for this variant (Variation ID: 264742). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg1332*) in the DEPDC5 gene. It is expected to result in an absent or disrupted protein product. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at